HMOX1 and melanoma: As marliolide (Figure 1A) was reported to increase antioxidant activity by promoting the expression of antioxidant enzymes, such as HO-1 and Nqo1 [16], we first investigated its hypopigmentation effects on B16F0 melanoma cells.